Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
36 results
D2.44 - Subjective assessment of sleep quality in adult patients with hereditary angioedema
D2.47 - Unmasking Melkersson-Rosenthal Syndrome: Diagnostic Challenges in a Patinent Pressenting With Angioedema
D2.57 - Evidence of Lower Airway Inflammation in Children with Allergic Rhinitis without Asthma
D2.43 - Hereditary Angioedema Can Hit at Any Age: A Case Report in Egypt
D2.45 - Fixed Drug Eruption Due to Fenofibrate Hypersensitivity
D2.46 - Patient with the overlap of Hereditary angioedema and Chronic spontaneous urticaria
D2.48 - When Treatment Becomes the Cause: Allergic Contact Dermatitis to Topical Corticosteroids
D2.49 - Quality of Life and Affecting Factors in Patients with Chronic Urticaria
D2.50 - When Angioedema Is Not Angioedema: Orofacial Sarcoidosis Mimicking Refractory Facial Swelling
D2.51 - Contact dermatitis due to continuous glucose monitoring sensors: limitations of standard patch testing
D2.53 - Impact of Smoking on the Clinical and Allergological Profile of Allergic Contact Dermatitis: An 8-Year Analytical Study
D2.54 - Correlation Between IgE Anti-Thyroid Peroxidase And Chronic Spontaneous Urticaria
D2.55 - Allergic contact dermatitis and cross-sensitization after laser-assisted 5-aminolevulinic acid PDT
D2.56 - Regionally Adapted Patch Test Panels Improve Diagnostic Resolution by Revealing Hidden Polysensitization in Allergic Contact Dermatitis
D2.216 - Effectiveness and safety of subcutaneous immunotherapy with Depigmented-Polymerized Cat Extract: real-world clinical evidence
D2.217 - Structured Follow-Up Intervals Enhance Adherence to Sublingual Immunotherapy in Patients with Allergic Rhinitis: Real-World Evidence from a Stepwise Approach
D2.218 - Effectiveness of the 300IR house dust mite sublingual tablet according to the patients’ sensitisation and allergy profile in the real-world, non-interventional VORAN study
D2.219 - Effectiveness of the 300IR house dust mite sublingual tablet in the real-world, non-interventional VORAN study: a responder analysis
D2.222 - A real-world observational study following the first year of SQ grass or SQ tree SLIT-tablet treatment to evaluate persistence and adherence in routine clinical practice among general practitioners in Norway
D2.225 - Characterizing skin-resident antigen presenting cell responses to plant-based Fel d 1 Bioparticles
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download